ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

ClinicalTrials.gov ID: NCT02047474

Public ClinicalTrials.gov record NCT02047474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 12:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer

Study identification

NCT ID
NCT02047474
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Yale University
Other
Enrollment
46 participants

Conditions and interventions

Interventions

  • fluorouracil Drug
  • irinotecan hydrochloride Drug
  • laboratory biomarker analysis Other
  • leucovorin calcium Drug
  • oxaliplatin Drug
  • therapeutic conventional surgery Procedure

Drug · Other · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2014
Primary completion
Aug 15, 2022
Completion
Jan 13, 2024
Last update posted
Mar 5, 2026

2014 – 2024

United States locations

U.S. sites
9
U.S. states
1
U.S. cities
9
Facility City State ZIP Site status
Smilow Cancer Hospital at Fairfield Fairfield Connecticut 06824
Smilow Cancer Hospital at Guilford Guilford Connecticut 06437
Smilow Cancer Hospital at St. Francis Hospital Hartford Connecticut 06105
Yale University New Haven Connecticut 06520-8032
Smilow Cancer Hospital at North Haven North Haven Connecticut 06473
Smilow Cancer Hospital at Orange Orange Connecticut 06477
Smilow Cancer Hospital at Torrington Torrington Connecticut 06790
Smilow Cancer Hospital at Trumbull Trumbull Connecticut 06611
Smilow Cancer Hospital at Waterbury Waterbury Connecticut 06708

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02047474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2026 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02047474 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →